Morgan Stanley’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33,970
| Closed | -$2.71M | – | 7946 |
|
|
2021
Q1 | $2.71M | Sell |
33,970
-47,824
| -58% | -$3.73M | ﹤0.01% | 4018 |
|
|
2020
Q4 | $6.45M | Buy |
81,794
+35,689
| +77% | +$2.09M | ﹤0.01% | 2987 |
|
|
2020
Q3 | $2.03M | Sell |
46,105
-79,608
| -63% | -$3.92M | ﹤0.01% | 3646 |
|
|
2020
Q2 | $5.56M | Buy |
125,713
+66,285
| +112% | +$2.47M | ﹤0.01% | 2555 |
|
|
2020
Q1 | $2.13M | Buy |
59,428
+10,991
| +23% | +$625K | ﹤0.01% | 3311 |
|
|
2019
Q4 | $3.43M | Buy |
48,437
+19,971
| +70% | +$1.45M | ﹤0.01% | 3593 |
|
|
2019
Q3 | $2.13M | Sell |
28,466
-2,862
| -9% | -$243K | ﹤0.01% | 3730 |
|
|
2019
Q2 | $2.53M | Sell |
31,328
-4,614
| -13% | -$324K | ﹤0.01% | 3591 |
|
|
2019
Q1 | $2.4M | Buy |
35,942
+11,249
| +46% | +$852K | ﹤0.01% | 3429 |
|
|
2018
Q4 | $1.84M | Sell |
24,693
-128,301
| -84% | -$10.6M | ﹤0.01% | 3840 |
|
|
2018
Q3 | $14.1M | Sell |
152,994
-77,381
| -34% | -$7.37M | ﹤0.01% | 2043 |
|
|
2018
Q2 | $22.7M | Buy |
230,375
+42,643
| +23% | +$4.77M | 0.01% | 1517 |
|
|
2018
Q1 | $20.9M | Buy |
187,732
+32,258
| +21% | +$3.62M | 0.01% | 1621 |
|
|
2017
Q4 | $16M | Buy |
155,474
+85,247
| +121% | +$8.49M | ﹤0.01% | 1907 |
|
|
2017
Q3 | $6.61M | Buy |
70,227
+11,457
| +19% | +$904K | ﹤0.01% | 2673 |
|
|
2017
Q2 | $4.58M | Sell |
58,770
-6,350
| -10% | -$477K | ﹤0.01% | 2935 |
|
|
2017
Q1 | $5.22M | Sell |
65,120
-128,030
| -66% | -$10.2M | ﹤0.01% | 2824 |
|
|
2016
Q4 | $15.2M | Buy |
193,150
+149,818
| +346% | +$11.6M | 0.01% | 1803 |
|
|
2016
Q3 | $3.38M | Sell |
43,332
-148,950
| -77% | -$10.8M | ﹤0.01% | 3050 |
|
|
2016
Q2 | $13.2M | Buy |
192,282
+174,401
| +975% | +$12M | ﹤0.01% | 1754 |
|
|
2016
Q1 | $1.27M | Sell |
17,881
-30,501
| -63% | -$1.91M | ﹤0.01% | 3723 |
|
|
2015
Q4 | $3.01M | Buy |
48,382
+31,633
| +189% | +$1.93M | ﹤0.01% | 3141 |
|
|
2015
Q3 | $949K | Sell |
16,749
-27,404
| -62% | -$1.45M | ﹤0.01% | 4150 |
|
|
2015
Q2 | $2.37M | Buy |
44,153
+22,042
| +100% | +$1.07M | ﹤0.01% | 3466 |
|
|
2015
Q1 | $1.05M | Buy |
22,111
+203
| +0.9% | +$8.99K | ﹤0.01% | 4095 |
|
|
2014
Q4 | $948K | Sell |
21,908
-33,580
| -61% | -$1.37M | ﹤0.01% | 4196 |
|
|
2014
Q3 | $1.91M | Buy |
55,488
+1,774
| +3% | +$62.7K | ﹤0.01% | 3478 |
|
|
2014
Q2 | $1.97M | Sell |
53,714
-33,598
| -38% | -$1.14M | ﹤0.01% | 3497 |
|
|
2014
Q1 | $2.94M | Sell |
87,312
-175,034
| -67% | -$5.77M | ﹤0.01% | 3091 |
|
|
2013
Q4 | $8.9M | Buy |
262,346
+211,825
| +419% | +$7.34M | ﹤0.01% | 2051 |
|
|
2013
Q3 | $1.61M | Buy |
50,521
+38,107
| +307% | +$1.01M | ﹤0.01% | 3407 |
|
|
2013
Q2 | $281K | Buy |
+12,414
| New | +$269K | ﹤0.01% | 4640 |
|
Morgan Stanley's CMD Position: Q2 2021 in Review
Morgan Stanley sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 33,970 shares — an estimated $2.71M sold.
Morgan Stanley first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $22.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Morgan Stanley reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Morgan Stanley sold 33,970 Cantel Medical Corporation shares in Q2 2021, an estimated $2.71M.
- Morgan Stanley first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Morgan Stanley's Cantel Medical Corporation position peaked at $22.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.